Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on June 9, 2025

Muslim AI Aims to Blend Technology, Companion and Spiritual Support for Users Worldwide
Introducing an inclusive AI companion designed to support Muslims through halal validation, mindful learning, companion …

Thinkstack Debuts Native Arabic AI Chatbot to Serve Growing MENA Market
Deploy native Arabic AI agents in 5 minutes. No English translation or reformatting; just localized training and human-like conversations. NEW YORK, NY, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- As businesses across the Middle East and North …

WAYS.cash Wins Grand Champion Title at Solrift Hackathon for Privacy-Focused Payment Toolkit
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- WAYS.cash, the first self-custodial stealth-address payment toolkit on Solana, has been named Grand Champion of the “A Breach in the Norm” hackathon hosted by Solrift. The win earned the New York–based project a …

CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
Lehi, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that it will expand its preclinical program to …

AB Science announces EMA approval of Masivet shelf-life extension to 4 years
PRESS RELEASE AB SCIENCE ANNOUNCES EMA APPROVAL OF MASIVET® SHELF-LIFE EXTENSION TO 4 YEARS Paris, June 9, 2025, 8am CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the European Medicine Agency (EMA) has approved the extension of the …

AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE L'APPROBATION PAR L'EMA DE LA PROLONGATION DE LA DURÉE DE CONSERVATION DE MASIVET® À 4 ANS Paris, 9 juin 2025, 8h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que l'Agence européenne des …

UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING Nantes, June 9th, 2025, 8 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) informs its shareholders and the market of the update on the terms of the Combined General Meeting scheduled …

MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE Nantes, France, 9 juin 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), informe ses actionnaires et le marché de la mise à jour des modalités de l’Assemblée Générale Mixte …

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025- …

Communiqué de presse : Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS
Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS Paris, le 9 juin 2025. Sanofi livrera Beyfortus (nirsevimab) dès le début du T3 pour assurer une large …